Developing Prediction Models for COVID-19 Outcomes: A Valuable Tool for Resource-Limited Hospitals

References

• WHO Coronavirus (COVID-19) Dashboard - Overview. 2023. Available from: https://covid19.who.int/. Accessed May 18, 2023.
   Google Scholar
• Kasapçopur Ö. Science and pseudoscience during the COVID-19 pandemic. Turk Pediatri Ars. 2020;55(4):335–336. doi:10.14744/TurkPediatriArs.2020.35902
   PubMedGoogle Scholar
• Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455. doi:10.1111/all.14657
   PubMed Web of Science ®Google Scholar
• Carpenter CR, Mudd PA, West CP, Wilber E, Wilber ST. Diagnosing COVID-19 in the Emergency Department: a Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases. Acad Emerg Med. 2020;27(8):653–670. doi:10.1111/acem.14048
   PubMed Web of Science ®Google Scholar
• Laza R, Lazureanu VE, Musta VF, et al. COVID-19 Independent Risk Factors for Unfavorable Disease Progression: a Cross-Sectional Study from Romania. Int J Gen Med. 2022;15:2025–2036. doi:10.2147/IJGM.S350920
   Web of Science ®Google Scholar
• Petermann-Rocha FK, Gray F, Jani SR, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One. 2020;15(11):e0241824. doi:10.1371/journal.pone.0241824
   PubMed Web of Science ®Google Scholar
• Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Global Health. 2021;6:e006434. doi:10.1136/bmjgh-2021-006434
   PubMed Web of Science ®Google Scholar
• Flaherty GT, Hession P, Liew CH, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16. doi:10.1186/s40794-020-00118-y
   PubMedGoogle Scholar
• García-Azorín D, Martínez-Pías E, Trigo J, et al. Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: a Cohort Study on 576 Patients. Front Neurol. 2020;11:781. doi:10.3389/fneur.2020.00781
   PubMed Web of Science ®Google Scholar
• Alberti P, Beretta S, Brighina L, Isella V, Ferrarese C. Impact of COVID–19 on pre-existing neurological diseases. In: Priori A, editor. NEUROLOGY of COVID–19 [Internet]. Milano, Italy: Milano University Press; 2021: 243–264
   Google Scholar
• Pecly IMD, Azevedo RB, Muxfeldt ES, et al. COVID-19 and chronic kidney disease: a comprehensive review. J Bras Nefrol. 2021;43(3):383–399. doi:10.1590/2175-8239-JBN-2020-0203
   PubMedGoogle Scholar
• Pakhchanian H, Raiker R, Mukherjee A, et al. Outcomes of COVID-19 in CKD Patients: a Multicenter Electronic Medical Record Cohort Study. Clin J Am Soc Nephrol. 2021;16(5):785–786. doi:10.2215/CJN.13820820
   PubMed Web of Science ®Google Scholar
• Li J, Guo T, Dong D, et al. Defining heart disease risk for death in COVID-19 infection. QJM. 2020;113(12):876–882. doi:10.1093/qjmed/hcaa246
   PubMed Web of Science ®Google Scholar
• Cordero A, García-Gallego SC, Bertomeu-González V, et al. Mortality associated with cardiovascular disease in patients with COVID-19. Rec Cardioclinics. 2021;56(1):30–38. doi:10.1016/j.rccl.2020.10.005
   Google Scholar
• Bouayed MZ, Laaribi I, Chatar CEM, et al. C-Reactive Protein (CRP): a poor prognostic biomarker in COVID-19. Front Immunol. 2022;13:1040024. doi:10.3389/fimmu.2022.1040024
   PubMedGoogle Scholar
• Lentner J, Adams T, Knutson V, et al. C-reactive protein levels associated with COVID-19 outcomes in the United States. J Osteopathic Med. 2021;121(12):869–873. doi:10.1515/jom-2021-0103
   PubMedGoogle Scholar
• Mosquera-Sulbaran JA, Pedreañez A, Carrero Y, Callejas D. C-reactive protein as an effector molecule in Covid-19 pathogenesis. Rev Med Virol. 2021;31(6):e2221. doi:10.1002/rmv.2221
   PubMed Web of Science ®Google Scholar
• Mocanu A, Lazureanu VE, Marinescu AR, et al. A Retrospective Assessment of Laboratory Findings and Cytokine Markers in Severe SARS-CoV-2 Infection among Patients of Roma Population. J Clin Med. 2022;11:6777. doi:10.3390/jcm11226777
   PubMed Web of Science ®Google Scholar
• Huang G, Kovalic AJ, Graber CJ. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. Emerg Infect Dis. 2020;26(8):1839–1841. doi:10.3201/eid2608.201160
   PubMed Web of Science ®Google Scholar
• Yamada T, Wakabayashi M, Yamaji T, et al. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): a systematic review and meta-analysis. Clin Chim Acta. 2020;509:235–243. doi:10.1016/j.cca.2020.06.008
   PubMed Web of Science ®Google Scholar
• Zhu B, Feng X, Jiang C, et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis. 2021;21(1):574. doi:10.1186/s12879-021-06277-3
   PubMed Web of Science ®Google Scholar
• McKenna E, Wubben R, Isaza-Correa JM, et al. Neutrophils in COVID-19: not Innocent Bystanders. Front Immunol. 2022;13:864387. doi:10.3389/fimmu.2022.864387
   PubMed Web of Science ®Google Scholar
• Agarwal N, Dua D, Sud R, Yadav M, Agarwal A, Vijayan V. COVID-19 mortality prediction model, 3C-M, built for use in resource limited settings - understanding the relevance of neutrophilic leukocytosis in predicting disease severity and mortality. medRxiv. 2021;2021:21261565. doi:10.1101/2021.08.05.21261565
   Google Scholar
• Hu H, Du H, Li J, et al. Early prediction and identification for severe patients during the pandemic of COVID-19: a severe COVID-19 risk model constructed by multivariate logistic regression analysis. J Glob Health. 2020;10(2):020510. doi:10.7189/jogh.10.020510
   PubMed Web of Science ®Google Scholar
• Huang J, Gao J, Zhu W, et al. Indicators and prediction models for the severity of Covid-19. Int J Clin Pract. 2021;75(10):e14571. doi:10.1111/ijcp.14571
   PubMedGoogle Scholar
• Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55:327–331. doi:10.1097/RLI.0000000000000672
   PubMed Web of Science ®Google Scholar
• Miller JL, Tada M, Goto M, et al. Prediction models for severe manifestations and mortality due to COVID-19: a systematic review. Acad Emerg Med. 2022;29(2):206–216. doi:10.1111/acem.14447
   PubMed Web of Science ®Google Scholar
• Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi:10.1136/bmj.m3339
   PubMed Web of Science ®Google Scholar
• Liu H, Chen J, Yang Q, et al. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Medicine. 2021;2(4):435–447.e4. doi:10.1016/j.medj.2020.12.013
   PubMedGoogle Scholar
• López A, Madurga R, Castellano JM, et al. Risk Score for Predicting In-Hospital Mortality in COVID-19 (RIM Score). Diagnostics. 2021;11:596. doi:10.3390/diagnostics11040596
   Web of Science ®Google Scholar